Cargando…
Severe hyperkalaemia: demographics and outcome
BACKGROUND: Few studies have evaluated the prevalence of severe hyperkalaemia in unselected patient populations. We identified all episodes of severe hyperkalaemia occurring in 1 year, and described patient demographics, clinical response and outcome. We also assessed junior doctor knowledge of its...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4377767/ https://www.ncbi.nlm.nih.gov/pubmed/25852860 http://dx.doi.org/10.1093/ckj/sft158 |
_version_ | 1782363954544115712 |
---|---|
author | Phillips, B.M. Milner, S. Zouwail, S. Roberts, G. Cowan, M. Riley, S.G. Phillips, A.O. |
author_facet | Phillips, B.M. Milner, S. Zouwail, S. Roberts, G. Cowan, M. Riley, S.G. Phillips, A.O. |
author_sort | Phillips, B.M. |
collection | PubMed |
description | BACKGROUND: Few studies have evaluated the prevalence of severe hyperkalaemia in unselected patient populations. We identified all episodes of severe hyperkalaemia occurring in 1 year, and described patient demographics, clinical response and outcome. We also assessed junior doctor knowledge of its causes and significance. MATERIALS AND METHODS: A retrospective interrogation of the database of the regional biochemical laboratory identified all episodes of severe hyperkalaemia (K≥ 6.5 mmol/L) occurring in 2011. The understanding of trainee doctors of the importance, causes and treatment of severe hyperkalaemia was assessed by structured questionnaire. RESULTS: Severe hyperkalaemia was recorded in 433 samples (365 patients) giving a prevalence of 0.11%. Thirty-six per cent of episodes occurred in patients under the care of a nephrologist, who were significantly younger than those not under the care of a nephrologist. In the nephrology cohort, 86% occurred in patients with chronic kidney disease (CKD), the majority of which had CKD Stage 5. In the non-nephrology cohort, only 65% occurred in the context of CKD, which was equally distributed between Stages 3 and 5 CKD. In both patient groups, roughly 50% of episodes occurred in association with acute kidney injury (AKI). Acute mortality (death within 48 h of documented severe hyperkalaemia) was higher in the non-nephrology compared with the nephrology cohort. Time to repeat serum potassium was influenced by the clinical setting with shorter time to repeat for acute care compared with ward settings. Assessment of trainee doctor's knowledge suggested significant deficiencies in relation to severe hyperkalaemia. CONCLUSIONS: The prevalence of severe hyperkalaemia was low and occurred predominantly in the context of CKD and/or AKI. The majority of episodes occurred in patients not under the care of a nephrologist. Variability in time to repeat serum potassium levels suggested deficiencies in care, and assessment of trainee doctor’s knowledge suggests the need for further educational initiatives to highlight its importance. |
format | Online Article Text |
id | pubmed-4377767 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2014 |
publisher | Oxford University Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-43777672015-04-07 Severe hyperkalaemia: demographics and outcome Phillips, B.M. Milner, S. Zouwail, S. Roberts, G. Cowan, M. Riley, S.G. Phillips, A.O. Clin Kidney J Original Contributions BACKGROUND: Few studies have evaluated the prevalence of severe hyperkalaemia in unselected patient populations. We identified all episodes of severe hyperkalaemia occurring in 1 year, and described patient demographics, clinical response and outcome. We also assessed junior doctor knowledge of its causes and significance. MATERIALS AND METHODS: A retrospective interrogation of the database of the regional biochemical laboratory identified all episodes of severe hyperkalaemia (K≥ 6.5 mmol/L) occurring in 2011. The understanding of trainee doctors of the importance, causes and treatment of severe hyperkalaemia was assessed by structured questionnaire. RESULTS: Severe hyperkalaemia was recorded in 433 samples (365 patients) giving a prevalence of 0.11%. Thirty-six per cent of episodes occurred in patients under the care of a nephrologist, who were significantly younger than those not under the care of a nephrologist. In the nephrology cohort, 86% occurred in patients with chronic kidney disease (CKD), the majority of which had CKD Stage 5. In the non-nephrology cohort, only 65% occurred in the context of CKD, which was equally distributed between Stages 3 and 5 CKD. In both patient groups, roughly 50% of episodes occurred in association with acute kidney injury (AKI). Acute mortality (death within 48 h of documented severe hyperkalaemia) was higher in the non-nephrology compared with the nephrology cohort. Time to repeat serum potassium was influenced by the clinical setting with shorter time to repeat for acute care compared with ward settings. Assessment of trainee doctor's knowledge suggested significant deficiencies in relation to severe hyperkalaemia. CONCLUSIONS: The prevalence of severe hyperkalaemia was low and occurred predominantly in the context of CKD and/or AKI. The majority of episodes occurred in patients not under the care of a nephrologist. Variability in time to repeat serum potassium levels suggested deficiencies in care, and assessment of trainee doctor’s knowledge suggests the need for further educational initiatives to highlight its importance. Oxford University Press 2014-04 2014-01-02 /pmc/articles/PMC4377767/ /pubmed/25852860 http://dx.doi.org/10.1093/ckj/sft158 Text en © The Author 2014. Published by Oxford University Press on behalf of ERA-EDTA. All rights reserved. For permissions, please email: journals.permissions@oup.com. http://creativecommons.org/licenses/by-nc/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact journals.permissions@oup.com |
spellingShingle | Original Contributions Phillips, B.M. Milner, S. Zouwail, S. Roberts, G. Cowan, M. Riley, S.G. Phillips, A.O. Severe hyperkalaemia: demographics and outcome |
title | Severe hyperkalaemia: demographics and outcome |
title_full | Severe hyperkalaemia: demographics and outcome |
title_fullStr | Severe hyperkalaemia: demographics and outcome |
title_full_unstemmed | Severe hyperkalaemia: demographics and outcome |
title_short | Severe hyperkalaemia: demographics and outcome |
title_sort | severe hyperkalaemia: demographics and outcome |
topic | Original Contributions |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4377767/ https://www.ncbi.nlm.nih.gov/pubmed/25852860 http://dx.doi.org/10.1093/ckj/sft158 |
work_keys_str_mv | AT phillipsbm severehyperkalaemiademographicsandoutcome AT milners severehyperkalaemiademographicsandoutcome AT zouwails severehyperkalaemiademographicsandoutcome AT robertsg severehyperkalaemiademographicsandoutcome AT cowanm severehyperkalaemiademographicsandoutcome AT rileysg severehyperkalaemiademographicsandoutcome AT phillipsao severehyperkalaemiademographicsandoutcome |